PAPER Friedland RP, Shah JJ, Farrer LA, Vardarajan B, Rebolledo-Mendez JD, Mok K, Hardy J
SEARCH RESULTS
330029 RESULTS
PAPER Li X, Lv Y, Yu S, Zhao H, Yao L
The effect of cadmium on Aβ levels in APP/PS1 transgenic mice.
Exp Ther Med. 2012 Jul;4(1):125-130. PubMed: 23060935PAPER Lykou E, Rankin KP, Chatziantoniou L, Boulas C, Papatriantafyllou O, Tsaousis I, Neuhaus J, Karageorgiou C, Miller BL, Papatriantafyllou JD
Big 5 Personality Changes in Greek bvFTD, AD, and MCI Patients.
Alzheimer Dis Assoc Disord. 2012 Oct 10; PubMed: 23060360PAPER Youmans KL, Tai LM, Nwabuisi-Heath E, Jungbauer L, Kanekiyo T, Gan M, Kim J, Eimer WA, Estus S, Rebeck GW, Weeber EJ, Bu G, Yu C, LaDu MJ
APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease.
J Biol Chem. 2012 Dec 7;287(50):41774-86. PubMed: 23060451PAPER Proft J, Weiss N
A protective mutation against Alzheimer disease?
Commun Integr Biol. 2012 Jul 1;5(4):301-3. PubMed: 23060947PAPER Tsuboi Y
Environmental-genetic interactions in the pathogenesis of Parkinson's disease.
Exp Neurobiol. 2012 Sep;21(3):123-8. PubMed: 23055790PAPER Kasuga K, Nishizawa M, Ikeuchi T
α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies.
Int J Alzheimers Dis. 2012;2012:437025. PubMed: 23056991PAPER Garriga-Canut M, Agustín-Pavón C, Herrmann F, Sánchez A, Dierssen M, Fillat C, Isalan M
Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 mice.
Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):E3136-45. PubMed: 23054839PAPER King A, Al-Sarraj S, Troakes C, Smith BN, Maekawa S, Iovino M, Spillantini MG, Shaw CE
Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant.
Acta Neuropathol. 2012 Sep 28; PubMed: 23053136PAPER Arhzaouy K, Strucksberg KH, Tung SM, Tangavelou K, Stumpf M, Faix J, Schröder R, Clemen CS, Eichinger L
Heteromeric p97/p97R155C complexes induce dominant negative changes in wild-type and autophagy 9-deficient Dictyostelium strains.
PLoS One. 2012;7(10):e46879. PubMed: 23056506PAPER Ando K, Obayashi S, Nagai Y, Oh-Nishi A, Minamimoto T, Higuchi M, Inoue T, Itoh T, Suhara T
PET analysis of dopaminergic neurodegeneration in relation to immobility in the MPTP-treated common marmoset, a model for Parkinson's disease.
PLoS One. 2012;7(10):e46371. PubMed: 23056291PAPER Jeong BH, Jin HT, Choi EK, Carp RI, Kim YS
Lack of association between 14-3-3 beta gene (YWHAB) polymorphisms and sporadic Creutzfeldt-Jakob disease (CJD).
Mol Biol Rep. 2012 Dec;39(12):10647-53. PubMed: 23053962PAPER Béraud D, Hathaway HA, Trecki J, Chasovskikh S, Johnson DA, Johnson JA, Federoff HJ, Shimoji M, Mhyre TR, Maguire-Zeiss KA
Microglial Activation and Antioxidant Responses Induced by the Parkinson's Disease Protein α-Synuclein.
J Neuroimmune Pharmacol. 2012 Oct 10; PubMed: 23054368PAPER Skjørringe T, Møller LB, Moos T
Impairment of interrelated iron- and copper homeostatic mechanisms in brain contributes to the pathogenesis of neurodegenerative disorders.
Front Pharmacol. 2012;3:169. PubMed: 23055972PAPER Shapshak P
Dementia and molecule of the month APP.
Bioinformation. 2012;8(14):644-5. PubMed: 23055603Current Filters
No filters selected